Description
Gina Columbus reports on FDA approvals in breast cancer and non-small cell lung cancer, a priority review designation in breast cancer, a new drug application accepted in hepatocellular carcinoma, a breakthrough therapy designation in Hodgkin lymphoma, and Japanese approvals in Merkel cell carcinoma and multiple myeloma.
Tags
cancer oncology